Athyrium Capital Management, LP

Filing Details

13F-HR • 2024-09-30
SEC
Report Date
2024-09-30
Filing Date
2024-11-12
Total Holdings
2
Total Value
8686216
Accession Number
0001123292-24-000336
Form Type
13F-HR
CIK
0001728001
Manager Name
Athyrium Capital Management, LP
Data Enrichment
50% identified
1 identified1 unidentified

Holdings

2 positions
Manager:
SEC
Search and click to pin securities to the top
74319F305
74319F305
Shares:
10929762(+0.0%)
Value:
$5.5B(-24.0%)
PUMA BIOTECHNOLOGY, INC.
PBYI|74587V107
Shares:
1256411(+0.0%)
Value:
$3.2B(-21.8%)